Product Images Vanrafia
View Photos of Packaging, Labels & Appearance
- Atrasentan structural formula - vanrafia 01
- Figure 1: Geometric Mean Percent Change from Baseline in UPCR by Visit in ALIGN - vanrafia 02
- PRINCIPAL DISPLAY PANEL NDC 0078-1420-15 Rx only VANRAFIA™ (atrasentan) tablets 0.75 mg Dispense with accompanying Medication Guide. Swallow tablets whole. Do not cut, crush, or chew. 30 tablets NOVARTIS - vanrafia 03
Product Label Images
The following 3 images provide visual information about the product associated with Vanrafia NDC 0078-1420 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Atrasentan structural formula - vanrafia 01
Figure 1: Geometric Mean Percent Change from Baseline in UPCR by Visit in ALIGN - vanrafia 02
PRINCIPAL DISPLAY PANEL NDC 0078-1420-15 Rx only VANRAFIA™ (atrasentan) tablets 0.75 mg Dispense with accompanying Medication Guide. Swallow tablets whole. Do not cut, crush, or chew. 30 tablets NOVARTIS - vanrafia 03
This text provides information about a medication called VANRAFIA™ in tablet form with a dosage of 0.75mg. It instructs to dispense it with the accompanying Medication Guide and to take the tablet whole without cutting or crushing it. There are 30 tablets in the pack. The recommended dosage and storage conditions are also provided. The product belongs to Novartis and includes a Global Trade Item Number (GTIN).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
